Johnson & Johnson Halts COVID-19 Vaccine Trial After Mystery Illness
It’s the second time in two months that a COVID-19 vaccine trial has been halted following an unexplained illness in a test subject, raising concerns about the safety of the vaccines and dampening expectations of a quick fix for the pandemic.
Researchers conducting the Johnson & Johnson trial, which includes 60,000 volunteers around the world, were told Monday to pause testing of the single-dose vaccine. The New Jersey-based corporation is one of a handful of companies in the world that has reached the final phase of testing on people.
“We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials … due to …continued .
[Source: Huffington Post]